A direct rate assay for plasminogen activator has been developed using a synthetic fluorogenic peptide substrate, 7(N-Cbz-glycylglycylargininamido)4-methylcoumarin trifluoroacetate. The assay correlates well with the standard 12SI-labeled fibrin plate assay using highly purified urokinase, culture fluids from WI-38, Chinese The enhanced production of plasminogen activator (PA) activity has been shown to be a characteristic of many different cell types. The intracellular and extracellular levels of PA have been demonstrated to be substantially elevated in malignant cells in culture (1-6), cells treated with a tumor promoter (7), activated macrophages (8, 9), established cell lines (10, 11), granulosa cells during ovulation (12), embryonic cells during differentiation (13, 14) , and hormone-treated uteri (15). The standard system used for measuring PA in these cells is an indirect, two-step assay in which plasminogen is incubated with a source of PA and the plasmin activity generated is quantitated by using fibrin, casein, or protamine as substrates (16) (17) (18) (19) . There is a need, however, for a simple, sensitive, direct assay that allows both rapid measurement and kinetic analysis of PA, independent of plasmin generation. In addition, the presence of two proteases of similar specificities in the two-step assay precludes the screening of potential PA inhibitors.
or Rous sarcoma virus-transformed chick fibroblasts as the source of plasminogen activator. The assay is sensitive, rapid, and linear throughout a wide range of enzyme concentrations. With this substrate it is possible to determine inhibitor profiles for the various plasminogen activators, independently of the interfering potential of plasmin. All of the enzymes tested are inhibited by leupeptin and antipain but not by the related aldehydes, elastatinal and chymostatin. The macromolecular inhibitors soybean trypsin inhibitor and trasylol have little or no effect on the plasminogen activators tested. This substrate should be useful for the study of the effect of various agents on functional changes in cells secreting this enzyme and also should allow kinetic measurements of potential inhibitors.
The enhanced production of plasminogen activator (PA) activity has been shown to be a characteristic of many different cell types. The intracellular and extracellular levels of PA have been demonstrated to be substantially elevated in malignant cells in culture (1) (2) (3) (4) (5) (6) , cells treated with a tumor promoter (7), activated macrophages (8, 9) , established cell lines (10, 11) , granulosa cells during ovulation (12) , embryonic cells during differentiation (13, 14) , and hormone-treated uteri (15) . The standard system used for measuring PA in these cells is an indirect, two-step assay in which plasminogen is incubated with a source of PA and the plasmin activity generated is quantitated by using fibrin, casein, or protamine as substrates (16) (17) (18) (19) . There is a need, however, for a simple, sensitive, direct assay that allows both rapid measurement and kinetic analysis of PA, independent of plasmin generation. In addition, the presence of two proteases of similar specificities in the two-step assay precludes the screening of potential PA inhibitors.
A series of synthetic fluorogenic substrates, specific for a number of serine proteases, utilizing the leaving group 7-amino-4-methylcoumarin (AMC) has been described (20, 21) . In a continuation of this approach, we have now prepared a synthetic peptide specific for the cleavage site of PA, incorporating the same leaving group. This compound is Cbz-GlyGly-Arg-AMC. We report here the use of this substrate in the direct fluorescent assay of PA from normal and malignant cells, some kinetic parameters of these enzymes, and the effect of various low and high molecular weight protease inhibitors on the various enzymes. The various PAs were analyzed by the direct fluorescent technique in parallel with the indirect standard 25I-labeled fibrin plate assay using purified plasminogens from both canine and bovine sources. (24) . When the cultures had attained high cell density (1 X 107 cells per 100-mm culture dish), the plates were washed three times with minimal medium and further incubated in serum-free minimal medium. The medium was removed from the cultures every 12 hr and was a source of extracellular PA; it is referred to as harvest fluid (HF). After it was harvested, the HF was immediately centrifuged to remove cells and cellular debris and acidified to pH 3.5 by the addition of 1 M HCl. Ammonium sulfate was added to 70% saturation, and the resulting precipitate was recovered by centrifugation and resuspended in 1/100 the volume of the original HF in 0.05 M glycine.HCI buffer, pH 3.0.
MATERIALS AND METHODS
WI-38, HeLa, and Chinese hamster ovary cells were grown in serum-containing medium, washed, and incubated in serum-free Higuchi medium (25) . This medium was removed after 24 or 48 hr and was the source of extracellular PA. These HFs were centrifuged, acidified, and concentrated as described for the Rous HF.
All of the HF concentrates were dialyzed for 16 
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The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. (20, 21) . Activation and emission wavelengths (383 and 455 nm, respectively) were chosen such that AMC retained 20% of its maximal fluorescence but possessed a relative fluorescence 500-fold greater than that of an equimolar amount of Cbz-Gly-Gly-Arg-AMC (Table 1 ). The instrument was standardized daily so that 10 nM AMC gave 1.0 chart division (0-100 scale).
Fibrin Plate Assay for PA. PA was assayed on 125I-labeled fibrin-coated petri dishes with purified plasminogen-free fibrinogen and purified fetal bovine or dog plasminogen as described (23) .
RESULTS Specificity and Kinetics of the Fluorometric Assay. Cbz-Gly-Gly-Arg-AMC is not only an excellent substrate for UK but also can be used to detect the presence of PA, either directly or after concentration in cultures with lower levels of activity, in the serum-free medium bathing various cells. Using this substrate, we measured PA activity secreted from HeLa, Chinese hamster ovary, and WI-38 cells and RSVCEF. As shown in Fig. 1 , the limit of detection of UK with this substrate and a reaction time as short as 5 min is 2.5 ng of protein per ml, and the rate of hydrolysis is proportional to enzyme concentration over at least a 400-fold range. The sensitivity could easily be increased by longer incubation times. The rate of hydrolysis of RSVCEF HF concentrate also is linear over at least a 100-fold range (Fig. 2) . The Km for UK with this fluorogenic substrate is 4 X 10-4 M; with the RSVCEF concentrate itis6X 10-4M.
Neither UK nor the RSVCEF activator hydrolyzed, at a significant rate, the fluorogenic substrates for elastase, trypsin, and chymotrypsin reported previously (11) . Conversely, Cbz-Gly-Gly-Arg-AMC is not significantly hydrolyzed by pancreatic elastase, granulocyte elastase, chymotrypsin, or granulocyte cathepsin G. However, like many arginine peptides, the substrate is hydrolyzed by trypsin, thrombin, and plasmin. The possible presence of the latter enzyme is monitored in our assay systems both by the plasminogen dependence any of the concentrates added to the fibrinolytic system. Therefore, the activity being detected in these fluids is indeed PA and not plasmin. The fluorogenic substrate, added as a stock concentrate in dimethylsulfoxide, has no effect on the fibrin plate assay; therefore, neither the substrate itself nor the vehicle at the concentrations used is inhibitory to either PA or plasmin.
Inhibitor Studies. Using the fluorogenic substrate, we determined the effect of various specific protease inhibitors on UK and the enzymes derived from various cell lines. chymostatin, an inhibitor of chymotrypsin-like enzymes, nor elastatinal, a specific inhibitor of elastase (27) , inhibited these activators at a concentration of 100 ,ug/ml. As expected, both UK and the RSVCEF enzyme were inhibited by diisopropylfluorophosphate. The response of PAs from various sources to several known inhibitors of trypsin-like enzymes is of considerable interest. As shown in Table 4 , all of the enzymes tested are inhibited by both leupeptin and antipain, but in all cases leupeptin is the better inhibitor. UK and the enzymes from HeLa, hamster ovary, and W138 cells have similar leupeptin/antipain inhibitory ratios but are not inhibited by trasylol or SBTI. The RSVCEF enzyme exhibits a leupeptin/antipain ratio similar to that of the other PAs but is inhibited slightly by SBTI. Plasmin is inhibited by much lower concentrations of all these inhibitors, again clearly demonstrating that we are measuring PA, not plasmin, in the extracellular fluids.
DISCUSSION
We have developed a direct rate assay for PA that uses a synthetic fluorogenic peptide. The assay results correlate with those of the standard fibrin plate assay using culture fluids from various cells as the source of PA. The assay is sensitive, rapid, and allows for the determination of kinetic constants and inhibitor profiles.
The sequence of the synthetic peptide was chosen to optimize the activity with PA. Kettner et al. (28) prepared a peptide chloromethyl ketone, with the sequence Ac-Gly-Gly-ArgCH2Cl, which inhibits UK 23-fold better than it inhibits plasmin (8) , identifying this sequence as being desirable. Huseby et al. (29) recently reported the detection of UK activity by using a similar peptide linked to the leaving group 4-methoxy-2-naphthylamine; however, the leaving group was detected indirectly by using a fast blue dye. In another approach to the direct assay of PA, Dano and Reich (30) reported a use of the macromolecular substrate, radiolabeled plasminogen. They determined hydrolysis of this substrate by electrophoresis, measuring the appearance of the heavy and light chains of plasmin.
Use of the substrate reported in this study has allowed us to 
